Keywords: مقاومت دارویی; Ovarian cancer; Clonal evolution; Genomic instability; Carboplatin; Drug resistance; Genetic heterogeneity;
مقالات ISI مقاومت دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مقاومت دارویی; NSLC, non-small cell lung cancer; SNP, single-nucleotide polymorphismCancer; Chemotherapeutics; Anticancer drugs; Doxorubicin (adriamycin); Cisplatin; Drug resistance; Biomarkers
Keywords: مقاومت دارویی; Cancer stem cells; Drug resistance; Molecular markers; Gastrointestinal tumors
Keywords: مقاومت دارویی; Antimicrobial susceptibility testing; Democratic Republic of the Congo; Drug resistance; Sequence analysis; Staphylococcus aureus;
Keywords: مقاومت دارویی; Drug resistance; Benzimidazole; β-tubulin; Polymorphisms; Mass drug administration;
Keywords: مقاومت دارویی; D-Alpha-tocopherol succinate (PubChem CID: 20353); RGD peptide (PubChem CID: 104802); Doxorubicin hydrochloride (PubChem CID: 443939); 4-Formylbenzoic acid (PubChem CID: 12088); DSPE-mPEG-2000 (PubChem CID: 86278269); D-α-tocopherol polyethylene glycol 1
Keywords: مقاومت دارویی; Membrane-active compounds; Membrane potential; Signal transduction; Host defense peptides; Oligomers of acylated cations; Drug resistance; Virulence;
Keywords: مقاومت دارویی; HIV-1; Adherence; Drug resistance; UDL; GSS;
Keywords: مقاومت دارویی; Heterogeneity; Cancer cell populations; Evolution; Drug resistance; Cancer therapeutics; Optimal control;
Keywords: مقاومت دارویی; Metals in medicine; Drug resistance; Ovarian cancer; Mechanism
Keywords: مقاومت دارویی; Mitochondria; Drug resistance; PI3K; Hsp90; Metastasis;
Keywords: مقاومت دارویی; Mycobacterium tuberculosis; Drug resistance; Sudan
Keywords: مقاومت دارویی; Urinary tract infection; Uropathogenic Escherichia coli; Drug resistance;
Keywords: مقاومت دارویی; Drug resistance; Malabsorption; Malaria; Malarone; Plasmodium falciparum;
Keywords: مقاومت دارویی; Drug resistance; epidemiology; Mycobacterium abscessus; non-tuberculous mycobacteria; transplantation
Keywords: مقاومت دارویی; Antiretroviral agents; cohort studies; drug resistance; epidemiological monitoring; human immunodeficiency virus;
Keywords: مقاومت دارویی; Drug resistance; Gulbarga; Tuberculosis
Keywords: مقاومت دارویی; prostatic neoplasms; biopsy; fluoroquinolones; drug resistance; bacterial; diabetes mellitus; AS; active surveillance; AUA; American Urological Association; FQ; fluoroquinolone; JHH; Johns Hopkins Hospital; TRUSB; transrectal ultrasound guided prostate bi
Keywords: مقاومت دارویی; urologic surgical procedures; antibiotic prophylaxis; physician's practice patterns; drug resistance; bacterial; quality of health careAMP, antimicrobial prophylaxis; AUA, American Urological Association; Bt, brachytherapy; HAI, hospital acquired infectio
Keywords: مقاومت دارویی; Bacteriuria; Drug resistance; Pregnant women; Urinary tract infection
Keywords: مقاومت دارویی; Tuberculosis; Type 2 diabetes; Risk factors; Multidrug resistance; TB-2DM comorbidity; Drug resistance;
Keywords: مقاومت دارویی; Wharton's jelly mesenchymal stem cells; Leukemia; Anticancer; Apoptosis; Human; Drug resistance
Keywords: مقاومت دارویی; Mycobacterium tuberculosis; Drug resistance; Children; China
Keywords: مقاومت دارویی; Trypanosoma vivax; Drug resistance; Cattle; Northwest Ethiopia;
Keywords: مقاومت دارویی; prostate; biopsy; antibiotic prophylaxis; fluoroquinolones; drug resistance; bacterialEP, empirical prophylaxis; FQ-R, fluoroquinolone resistant; TP, targeted prophylaxis; TRPB, transrectal prostate biopsy
Keywords: مقاومت دارویی; Diagnosis; Screening; Case detection; Drug resistance; Point of care
Keywords: مقاومت دارویی; Periodontitis; Periodontal pocket; Antibiotics; Microbial sensitivity tests; Drug resistance; Drug therapy
Keywords: مقاومت دارویی; Drug resistance; Nematodes; Cestodes; Valerolactam-benzimidazole hybrids; Haemonchus contortus; Mesocestoides vogae; BZ; benzimidazoles; ABZ; albendazole; FLU; flubendazole; FEB; febendazole; ABZ SX; albendazole sulfoxide; FEB SX; febendazole sulfoxide;
Keywords: مقاومت دارویی; Malaria; Plasmodium falciparum; Plasmodium vivax; Drug resistance; Artemisinin resistance; Molecular markers
Keywords: مقاومت دارویی; DXR, doxorubicin resistance; HMG, high mobility group; WT, wild-type; HR, homologous recombinationDoxorubicin; Drug resistance; High mobility group; Rhp54; Hap2; Nht1; Fission yeast; S. pombe
Keywords: مقاومت دارویی; AIDS; Tuberculosis; TB; Infection; Drug resistance
Keywords: مقاومت دارویی; Plasmodium falciparum; Drug resistance; MAL10-688956; MAL13-1718319; Artemisinin combination therapy;
Keywords: مقاومت دارویی; ERK; extracellular signal-regulated kinase; EGFR; epidermal growth factor receptor; ELISA; enzyme-linked immunosorbent assay; FFPE; formalin-fixed paraffin-embedded; FISH; fluorescence in situ hybridization; FNA; fine-needle aspiration; F/RPPA; forward/re
Keywords: مقاومت دارویی; Leishmania amazonensis; Chemotherapy; Drug resistance; TamoxifenTM, tamoxifen; MNNG, N-methyl-N-nitroso-N′-nitroguanidine; MT, miltefosine transporter; PBS, phosphate buffered solution; NBD-PC, 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-hexa
Keywords: مقاومت دارویی; Gene mutation; Tumor relapse; Drug resistance; Proteomics; MALDI-imaging; Mutation génétique; Rechute tumorale; Résistance aux médicaments; Protéomique; MALDI-TOF;
Keywords: مقاومت دارویی; drug resistance; ermA gene; erythromycin; levofloxacin; macrolide; mef gene; quinolone; vaginal infection;
Keywords: مقاومت دارویی; Synergistic treatment; shSox2; Doxorubicin; Cancer stem cells (CSCs); Drug resistance
Keywords: مقاومت دارویی; integrins; cancer; drug resistance; stemness
Keywords: مقاومت دارویی; Tumor microenvironment; Drug resistance; Combination therapy;
Keywords: مقاومت دارویی; Chemotherapy; Drug resistance; Metastatic breast cancer; Progression free survival; Response rate;
Keywords: مقاومت دارویی; drug resistance; coinfection; immune modulation; resource competition; parasite interactions
Keywords: مقاومت دارویی; Monitoring; Anthelmintic drugs; Drug efficacy; Drug resistance
Keywords: مقاومت دارویی; Metalloproteins; Cisplatin; Drug resistance; DFT; Hybrid QM/MM simulations; Computational spectroscopy;
Keywords: مقاومت دارویی; Dental plaque; dental pulp cavity; drug resistance; saliva
Keywords: مقاومت دارویی; Pgp; P-glycoprotein; SCT; sucrose/saccharin consumption test; SE; status epilepticus; SRS; spontaneous recurrent seizures; TLE; temporal-lobe epilepsy; Anhedonia; Drug resistance; Animal model; Pilocarpine; Kainic acid;
Keywords: مقاومت دارویی; membrane proteins; drug resistance; transport mechanism
Keywords: مقاومت دارویی; Influenza A virus; H7N9; NA9; Mutation; Drug resistance;
Keywords: مقاومت دارویی; Tumor genome sequencing; Cancer systems biology; Network; Cancer hallmark network framework; Cancer hallmark; Gene regulatory profile; Regulatory Phenotype; Clinical phenotype; Network operational signature; Drug resistance; Personalized medicine;
Keywords: مقاومت دارویی; Living cells; Chemotherapy; Drug resistance; Multi-bounce ATR; Drug screening; Infrared spectroscopy;
Keywords: مقاومت دارویی; Hypoxia; Lung adenocarcinoma; Cancer stem cells; Drug resistance; CD166;